AUREKA LIMITED — Major Shareholding Notification 2021

Jun 3, 2021

604 page 1/2

15 July 2001

Form 604 Corporations Act 2001 Section 671B

Notice of change of interests of substantial holder

To Company Name/Scheme

NAVARRE MINERALS LIMITED

ACN/ARSN

125 140 105

1. Details of substantial holder (1) Name ACN/ARSN (if applicable)

Dr Stephen Garth Nordstrom N/A

There was a change in the interests of the substantial holder on The previous notice was given to the company on The previous notice was dated

19/02/2021 – 02/06/2021 19/02/2021 19/02/2021

2. Previous and present voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:

Class of securities (4)	Previous notice	Previous notice	Present notice	Present notice
	Person’s votes	Voting power(5)	Person’s votes	Voting power(5)
Fully paid ordinaryshares	46,000,000	8.44%	46,600,000	7.21%

3. Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

	Date of change	Person whose relevant interest changed	Nature of change (6)	Consideration given in relation to change (7)	Class and number of securities affected	Person’s votes affected
	24/02/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$29,034.80	200,000 Fully paid ordinaryshares	200,000
	24/02/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$22,234.81	150,000 Fully paid ordinaryshares	150,000
	26/02/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$21,779.95	150,000 Fully paid ordinaryshares	150,000
	03/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$15,029.95	100,000 Fully paid ordinaryshares	100,000
	03/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$14,029.94	100,000 Fully paid ordinaryshares	100,000
	03/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$14,529.94	100,000 Fully paid ordinaryshares	100,000
			Dilutionary impact due to
	04/03/2021	Dr Stephen Garth Nordstrom	issue of shares by the	-	-	-
			Company
	05/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$15,029.95	100,000 Fully paid ordinaryshares	100,000
	05/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$5,276.64	36,253 Fully paid ordinaryshares	36,253
	08/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$9.572.05	63,747 Fully paid ordinaryshares	63,747
	09/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$29,034.80	200,000 Fully paid ordinaryshares	200,000
	10/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$21,029.95	150,000 Fully paid ordinaryshares	150,000
	10/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$14,029.95	100,000 Fully paid ordinaryshares	100,000
	10/03/2021	Dr Stephen Garth Nordstrom	Sale on Market	($13,040.73)	93,362 Fully paid ordinaryshares	(93,362)
	11/03/2021	Dr Stephen Garth Nordstrom	Sale on Market	($962.51)	6,638 Fully paid ordinaryshares	(6,638)
	11/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$7,269.95	50,000 Fully paid ordinaryshares	50,000
	11/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$7,519.95	50,000 Fully paid ordinary shares	50,000
	11/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$7,519.95	50,000 Fully paid ordinary shares	50,000
	12/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$38,796.49	250,000 Fully paid ordinaryshares	250,000
	12/03/2021	Dr Stephen Garth Nordstrom	Acquisition on market	$22,338.17	143,924 Fully paid ordinaryshares	143,924

604 page 2/2 15 July 2001	604 page 2/2 15 July 2001	604 page 2/2 15 July 2001	604 page 2/2 15 July 2001	604 page 2/2 15 July 2001	604 page 2/2 15 July 2001	604 page 2/2 15 July 2001	604 page 2/2 15 July 2001	604 page 2/2 15 July 2001	604 page 2/2 15 July 2001	604 page 2/2 15 July 2001
15/03/2021	Dr Stephen Garth Nordstrom		Acquisition on market		$17,520.36		106,076 Fully paid ordinaryshares		106,076
15/03/2021	Dr Stephen Garth Nordstrom		Acquisition on market		$31,037.20		200,000 Fully paid ordinaryshares		200,000
15/03/2021	Dr Stephen Garth Nordstrom		Acquisition on market		$3,277.12		21,014 Fully paid ordinaryshares		21,014
16/03/2021	Dr Stephen Garth Nordstrom		Acquisition on market		$20,002.83		128,986 Fully paid ordinaryshares		128,986
16/03/2021	Dr Stephen Garth Nordstrom		Acquisition on market		$23,279.95		150,000 Fully paid ordinaryshares		150,000
16/03/2021	Dr Stephen Garth Nordstrom		Acquisition on market		$23,279.95		150,000 Fully paid ordinaryshares		150,000
16/03/2021	Dr Stephen Garth Nordstrom		Acquisition on market		$23,279.95		150,000 Fully paid ordinaryshares		150,000
16/03/2021	Dr Stephen Garth Nordstrom		Acquisition on market		$14,529.95		100,000 Fully paid ordinaryshares		100,000
16/03/2021	Dr Stephen Garth Nordstrom		Acquisition on market		$15,029.95		100,000 Fully paid ordinaryshares		100,000
19/03/2021	Dr Stephen Garth Nordstrom		Dilutionary impact due to issue of shares by the Company		-		-		-
07/04/2021	Dr Stephen Garth Nordstrom		Acquisition on market		$1,519.95		10,000 Fully paid ordinaryshares		10,000
26/04/2021	Dr Stephen Garth Nordstrom		Sale on Market		($609.92)		4,428 Fully paid ordinaryshares		(4,428)
27/04/2021	Dr Stephen Garth Nordstrom		Sale on Market		($13,740.13)		105,572 Fully paid ordinaryshares		(105,572)
30/04/2021	Dr Stephen Garth Nordstrom		Sale on Market		($31,212.50)		250,000 Fully paid ordinaryshares		(250,000)
30/04/2021	Dr Stephen Garth Nordstrom		Sale on Market		($220,734.80)		1,700,000 Fully paid ordinaryshares		(1,700,000)
03/05/2021	Dr Stephen Garth Nordstrom		Acquisition on market		$6,019.95		50,000 Fully paid ordinaryshares		50,000
26/05/2021	Dr Stephen Garth Nordstrom		Sale on Market		(43,947.20)		400,000 Fully paid ordinaryshares		(400,000)
02/06/2021	Dr Stephen Garth Nordstrom		Dilutionary impact due to issue of shares by the Company		-		-		-
. Present relevant interests articulars of each relevant interest of the substantial holder in votingsecurities after the change are as follows:
Holder of relevant interest		Registered holder of securities		Person entitled to be registered as holder (8)		Nature of relevant interest (6)		Class and number of securities		Person’s votes
Dr Stephen Garth Nordstrom		Dr Stephen Garth Nordstrom		Dr Stephen Garth Nordstrom		Power to exercise vote and/or power to dispose of the shares		46,600,000 Fully paid ordinary shares		46,600,000

5. Changes in association

The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if applicable) Nature of association N/A . Addresses he addresses of persons named in this form are as follows: Name Address Dr Stephen Garth Nordstrom 83 Empire BayDr Daleys Point NSW 2257	Name and ACN/ARSN (if applicable)	Nature of association
	N/A
	Name	Address
	Dr Stephen Garth Nordstrom	83 Empire BayDr Daleys Point NSW 2257

Signature

print nameDr Stephen Garth Nordstrom	capacity
sign here	date	04/06/2021

Bris_docs/8665181_1

604 page 2/2 15 July 2001

DIRECTIONS

• (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.

• (2) See the definition of "associate" in section 9 of the Corporations Act 2001.

• (3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

• (4) The voting shares of a company constitute one class unless divided into separate classes.

• (5) The person’s votes divided by the total votes in the body corporate or scheme multiplied by 100.

• (6) Include details of:

• (a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

• (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

• (7) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included on any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

• (8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write “unknown’”.

• (9) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.

Bris_docs/8665181_1